| Emerging influenza D virus threat: what we know so far! K Asha, B Kumar Journal of Clinical Medicine 8 (2), 192, 2019 | 181 | 2019 |
| The emerging influenza virus threat: status and new prospects for its therapy and control B Kumar, K Asha, M Khanna, L Ronsard, CA Meseko, M Sanicas Archives of virology 163, 831-844, 2018 | 114 | 2018 |
| Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors K Asha, A Singal, SB Sharma, VK Arora, A Aggarwal Indian Journal of Medical Research 146 (6), 708-713, 2017 | 62 | 2017 |
| Hedgehog signaling: Implications in cancers and viral infections S Iriana, K Asha, M Repak, N Sharma-Walia International Journal of Molecular Sciences 22 (3), 1042, 2021 | 56 | 2021 |
| Advancements in nucleic acid based therapeutics against respiratory viral infections K Asha, P Kumar, M Sanicas, CA Meseko, M Khanna, B Kumar Journal of Clinical Medicine 8 (1), 6, 2018 | 50 | 2018 |
| Association of carotid intima-media thickness with leptin and apolipoprotein B/apolipoprotein AI ratio reveals imminent predictors of subclinical atherosclerosis in psoriasis … K Asha, SB Sharma, A Singal, A Aggarwal Acta Medica (Hradec Kralove) 57 (1), 21-27, 2014 | 32 | 2014 |
| Salubrinal exposes anticancer properties in inflammatory breast cancer cells by manipulating the endoplasmic reticulum stress pathway A Alsterda, K Asha, O Powrozek, M Repak, S Goswami, AM Dunn, ... Frontiers in Oncology 11, 654940, 2021 | 23 | 2021 |
| Concurrent control of the kaposi's sarcoma-associated herpesvirus life cycle through chromatin modulation and host hedgehog signaling: A new prospect for the therapeutic … K Asha, N Balfe, N Sharma-Walia Journal of Virology 94 (9), 10.1128/jvi. 02177-19, 2020 | 17 | 2020 |
| HACE1, an E3 ubiquitin protein ligase, mitigates Kaposi’s Sarcoma-associated herpesvirus infection-induced oxidative stress by promoting Nrf2 activity B Kumar, A Roy, K Asha, N Sharma-Walia, MA Ansari, B Chandran Journal of Virology 93 (9), 10.1128/jvi. 01812-18, 2019 | 16 | 2019 |
| PI3K/Akt/ Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection. KB Lekshmi VS, Asha K, Sanicas M, Asi A, Arya UM Front. Mol. Biosci. 10, 2023 | 15 | 2023 |
| Targeting host cellular factors as a strategy of therapeutic intervention for herpesvirus infections K Asha, N Sharma-Walia Frontiers in Cellular and Infection Microbiology 11, 603309, 2021 | 15 | 2021 |
| Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics K Asha, N Sharma-Walia Oncotarget 9 (61), 31920, 2018 | 15 | 2018 |
| Current insights into the host immune response to respiratory viral infections K Asha, M Khanna, B Kumar Microbial Pathogenesis: Infection and Immunity, 59-83, 2021 | 10 | 2021 |
| Antiviral options and therapeutics against influenza: history, latest developments and future prospects CA Meseko, M Sanicas, K Asha, L Sulaiman, B Kumar Frontiers in Cellular and Infection Microbiology 13, 1269344, 2023 | 9 | 2023 |
| DNAzyme mediated post-transcriptional gene silencing: A novel therapeutic approach B Kumar, K Asha, SPS Chauhan | 4 | 2013 |
| Influenza and related viruses: Epidemiology, pathogenesis, and therapeutics K Asha, C Meseko, B Kumar Frontiers in Molecular Biosciences 9, 1117067, 2023 | 3 | 2023 |
| Psoriasis and Atherosclerosis: Shared Pathogenesis and Diagnostic Approach. SB Sharma, A Singal, K Asha, A Aggarwal Indian Journal of Clinical Biochemistry 29 (S1), S11-S11, 2014 | | 2014 |
Binod Kumar, Ph.D.Loyola University Chicago (2019-2021); Chicago Medical School (2014-2019)Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα luc.edu